The B7:CD28 receptor family members provide activating or inhibitory signals that are critical regulators of the inflammatory process and T cell function in vitro and in vivo. These receptors exert there influence throughout the inflammatory response, regulating the initiation, effector and resolution phases of allergic airway inflammation. CD28 is required for allergic airway inflammation in a murine model of asthma. Interestingly, the resolution of inflammation is also an active process that depends upon signaling through inhibitory receptors of the B7:CD28 family. Thus, in vivo, continued inflammation or resolution is determined by the balance of activating versus inhibitory signals delivered through receptors of the B7:CD28 family. While headway has been made in understanding the mechanism of CD28 and related proteins, significant questions remain as to how these signals are integrated to yield specific immune responses. Our studies have determined that CD28 regulates both the initiation of T cell activation, as well as the maintenance of effector function. We have identified distinct signaling motifs in the cytoplasmic tail of CD28 that selectively regulate T cell proliferation, cytokine secretion and survival in vitro. We hypothesize that these domains, termed the proximal and distal CD28 signaling motifs, regulate the initiation and maintenance of effector function in vivo. We have generated knock in mice expressing specific point mutations in the proximal and distal CD28 signaling motifs. These are a novel and potent tool to dissect how the cellular and biochemical consequences of CD28 ligation are integrated in vitro and in vivo.
In Specific Aim 1 we will utilize these to determine how signals from the proximal and distal CD28 signaling motifs regulate allergic airway inflammation. To determine how CD28 signaling is counterbalanced, we have obtained mice deficient in the newly described B and T Lymphocyte attenuator (BTLA), an inhibitory receptor of the CD28 family. Our Preliminary Data demonstrates that BTLA is important in limiting lung inflammation. We hypothesize that the expression of BTLA on activated T cells is engaged by ligands on cells in the lung, and that this signal terminates the inflammatory response.
In Specific Aim 2 we will test this and determine the mechanism by which BTLA limits inflammation. Characterization of the balance between activating and inhibitory signals from the B7:CD28 receptor family members will provide the framework to develop strategies to manipulate either activating or inhibitory signals to favorably alter the initiation, effector, and resolution phases of allergic inflammation. ? ?

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Noel, Patricia
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Internal Medicine/Medicine
Schools of Medicine
Saint Louis
United States
Zip Code
Gmyrek, Grzegorz B; Pingel, Jeanette; Choi, Jaehyuk et al. (2017) Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma. Cell Immunol 319:28-34
Rozanski, Cheryl H; Utley, Adam; Carlson, Louise M et al. (2015) CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif. J Immunol 194:4717-28
Mahmud, Shawn A; Manlove, Luke S; Schmitz, Heather M et al. (2014) Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat Immunol 15:473-81
Boomer, Jonathan S; Deppong, Christine M; Shah, Dulari D et al. (2014) Cutting edge: A double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression. J Immunol 192:3465-9
Deppong, Christine M; Bricker, Traci L; Rannals, Brandy D et al. (2013) CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-?. J Immunol 191:3082-9
Deppong, Christine M; Green, Jonathan M (2013) Experimental advances in understanding allergic airway inflammation. Front Biosci (Schol Ed) 5:167-80
Pagán, Antonio J; Pepper, Marion; Chu, H Hamlet et al. (2012) CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J Immunol 189:2909-17
Deppong, Christine M; Xu, Jian; Brody, Steven L et al. (2012) Airway epithelial cells suppress T cell proliferation by an IFN?/STAT1/TGF?-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 302:L167-73
Vang, Kieng B; Yang, Jianying; Pagán, Antonio J et al. (2010) Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. J Immunol 184:4074-7
Boomer, Jonathan S; Green, Jonathan M (2010) An enigmatic tail of CD28 signaling. Cold Spring Harb Perspect Biol 2:a002436

Showing the most recent 10 out of 19 publications